List of Tables
Table 1. Global Adult Preventable Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Adult Preventable Vaccines Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Adult Preventable Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Adult Preventable Vaccines Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Adult Preventable Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Adult Preventable Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Adult Preventable Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Adult Preventable Vaccines Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Adult Preventable Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Adult Preventable Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adult Preventable Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Adult Preventable Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adult Preventable Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Preventable Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adult Preventable Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Adult Preventable Vaccines Sales by Region (2019-2024) & (K Dose)
Table 18. Global Adult Preventable Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Adult Preventable Vaccines Sales by Region (2025-2030) & (K Dose)
Table 20. Global Adult Preventable Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Adult Preventable Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Adult Preventable Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Adult Preventable Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Adult Preventable Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Adult Preventable Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Adult Preventable Vaccines Sales by Country (2019-2024) & (K Dose)
Table 27. North America Adult Preventable Vaccines Sales by Country (2025-2030) & (K Dose)
Table 28. North America Adult Preventable Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Adult Preventable Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Adult Preventable Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Adult Preventable Vaccines Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Adult Preventable Vaccines Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Adult Preventable Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Adult Preventable Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Adult Preventable Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Adult Preventable Vaccines Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Adult Preventable Vaccines Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Adult Preventable Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Adult Preventable Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Adult Preventable Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Adult Preventable Vaccines Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Adult Preventable Vaccines Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Adult Preventable Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Adult Preventable Vaccines Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Adult Preventable Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Adult Preventable Vaccines Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Adult Preventable Vaccines Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Adult Preventable Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Adult Preventable Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Adult Preventable Vaccines Sales (K Dose) by Type (2019-2024)
Table 51. Global Adult Preventable Vaccines Sales (K Dose) by Type (2025-2030)
Table 52. Global Adult Preventable Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Adult Preventable Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Adult Preventable Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Adult Preventable Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Adult Preventable Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Adult Preventable Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2019-2024)
Table 59. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2025-2030)
Table 60. Global Adult Preventable Vaccines Sales (K Dose) by Application (2019-2024)
Table 61. Global Adult Preventable Vaccines Sales (K Dose) by Application (2025-2030)
Table 62. Global Adult Preventable Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Adult Preventable Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Adult Preventable Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Adult Preventable Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Adult Preventable Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Adult Preventable Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2019-2024)
Table 69. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2025-2030)
Table 70. Pfizer Inc. Company Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Pfizer Inc. Adult Preventable Vaccines Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Merck & Co., Inc. Company Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Merck & Co., Inc. Adult Preventable Vaccines Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. GlaxoSmithKline plc (GSK) Company Information
Table 81. GlaxoSmithKline plc (GSK) Description and Business Overview
Table 82. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. GlaxoSmithKline plc (GSK) Adult Preventable Vaccines Product
Table 84. GlaxoSmithKline plc (GSK) Recent Developments/Updates
Table 85. Sanofi Pasteur Company Information
Table 86. Sanofi Pasteur Description and Business Overview
Table 87. Sanofi Pasteur Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Sanofi Pasteur Adult Preventable Vaccines Product
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Moderna, Inc. Company Information
Table 91. Moderna, Inc. Description and Business Overview
Table 92. Moderna, Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Moderna, Inc. Adult Preventable Vaccines Product
Table 94. Moderna, Inc. Recent Developments/Updates
Table 95. Serum Institute of India Pvt. Company Information
Table 96. Serum Institute of India Pvt. Description and Business Overview
Table 97. Serum Institute of India Pvt. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Serum Institute of India Pvt. Adult Preventable Vaccines Product
Table 99. Serum Institute of India Pvt. Recent Developments/Updates
Table 100. Bharat Biotech International Company Information
Table 101. Bharat Biotech International Description and Business Overview
Table 102. Bharat Biotech International Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Bharat Biotech International Adult Preventable Vaccines Product
Table 104. Bharat Biotech International Recent Developments/Updates
Table 105. CSL Limited (Seqirus) Company Information
Table 106. CSL Limited (Seqirus) Description and Business Overview
Table 107. CSL Limited (Seqirus) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. CSL Limited (Seqirus) Adult Preventable Vaccines Product
Table 109. CSL Limited (Seqirus) Recent Developments/Updates
Table 110. Emergent BioSolutions Inc. Company Information
Table 111. Emergent BioSolutions Inc. Description and Business Overview
Table 112. Emergent BioSolutions Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Emergent BioSolutions Inc. Adult Preventable Vaccines Product
Table 114. Emergent BioSolutions Inc. Recent Developments/Updates
Table 115. Daiichi Sankyo Company Company Information
Table 116. Daiichi Sankyo Company Description and Business Overview
Table 117. Daiichi Sankyo Company Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Daiichi Sankyo Company Adult Preventable Vaccines Product
Table 119. Daiichi Sankyo Company Recent Developments/Updates
Table 120. Novavax, Inc. Company Information
Table 121. Novavax, Inc. Description and Business Overview
Table 122. Novavax, Inc. Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Novavax, Inc. Adult Preventable Vaccines Product
Table 124. Novavax, Inc. Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Sinovac Biotech Adult Preventable Vaccines Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Sinopharm Group Co., Company Information
Table 131. Sinopharm Group Co., Description and Business Overview
Table 132. Sinopharm Group Co., Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 133. Sinopharm Group Co., Adult Preventable Vaccines Product
Table 134. Sinopharm Group Co., Recent Developments/Updates
Table 135. Johnson & Johnson (Janssen) Company Information
Table 136. Johnson & Johnson (Janssen) Description and Business Overview
Table 137. Johnson & Johnson (Janssen) Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 138. Johnson & Johnson (Janssen) Adult Preventable Vaccines Product
Table 139. Johnson & Johnson (Janssen) Recent Developments/Updates
Table 140. AstraZeneca plc Company Information
Table 141. AstraZeneca plc Description and Business Overview
Table 142. AstraZeneca plc Adult Preventable Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 143. AstraZeneca plc Adult Preventable Vaccines Product
Table 144. AstraZeneca plc Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Adult Preventable Vaccines Distributors List
Table 148. Adult Preventable Vaccines Customers List
Table 149. Adult Preventable Vaccines Market Trends
Table 150. Adult Preventable Vaccines Market Drivers
Table 151. Adult Preventable Vaccines Market Challenges
Table 152. Adult Preventable Vaccines Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adult Preventable Vaccines
Figure 2. Global Adult Preventable Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Adult Preventable Vaccines Market Share by Type: 2023 & 2030
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Mrna Vaccines Product Picture
Figure 7. Viral Vector Vaccines Product Picture
Figure 8. Peptide Vaccines Product Picture
Figure 9. Global Adult Preventable Vaccines Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Adult Preventable Vaccines Market Share by Application: 2023 & 2030
Figure 11. Prevent Influenza
Figure 12. Prevent Pneumococcal Infection
Figure 13. Prevent Hepatitis B
Figure 14. Prevent Herpes Zoster
Figure 15. Prevent Human Papillomavirus (Hpv)
Figure 16. Other
Figure 17. Global Adult Preventable Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Adult Preventable Vaccines Market Size (2019-2030) & (US$ Million)
Figure 19. Global Adult Preventable Vaccines Sales (2019-2030) & (K Dose)
Figure 20. Global Adult Preventable Vaccines Average Price (US$/Dose) & (2019-2030)
Figure 21. Adult Preventable Vaccines Report Years Considered
Figure 22. Adult Preventable Vaccines Sales Share by Manufacturers in 2023
Figure 23. Global Adult Preventable Vaccines Revenue Share by Manufacturers in 2023
Figure 24. Global 5 and 10 Largest Adult Preventable Vaccines Players: Market Share by Revenue in Adult Preventable Vaccines in 2023
Figure 25. Adult Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Adult Preventable Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. North America Adult Preventable Vaccines Sales Market Share by Country (2019-2030)
Figure 28. North America Adult Preventable Vaccines Revenue Market Share by Country (2019-2030)
Figure 29. United States Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Canada Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Europe Adult Preventable Vaccines Sales Market Share by Country (2019-2030)
Figure 32. Europe Adult Preventable Vaccines Revenue Market Share by Country (2019-2030)
Figure 33. Germany Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. France Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. U.K. Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Italy Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Russia Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Asia Pacific Adult Preventable Vaccines Sales Market Share by Region (2019-2030)
Figure 39. Asia Pacific Adult Preventable Vaccines Revenue Market Share by Region (2019-2030)
Figure 40. China Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Japan Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. South Korea Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. India Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. China Taiwan Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Adult Preventable Vaccines Sales Market Share by Country (2019-2030)
Figure 48. Mexico Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Colombia Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East and Africa Adult Preventable Vaccines Sales Market Share by Country (2019-2030)
Figure 53. Middle East and Africa Adult Preventable Vaccines Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Adult Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Adult Preventable Vaccines by Type (2019-2030)
Figure 58. Global Revenue Market Share of Adult Preventable Vaccines by Type (2019-2030)
Figure 59. Global Adult Preventable Vaccines Price (US$/Dose) by Type (2019-2030)
Figure 60. Global Sales Market Share of Adult Preventable Vaccines by Application (2019-2030)
Figure 61. Global Revenue Market Share of Adult Preventable Vaccines by Application (2019-2030)
Figure 62. Global Adult Preventable Vaccines Price (US$/Dose) by Application (2019-2030)
Figure 63. Adult Preventable Vaccines Value Chain
Figure 64. Adult Preventable Vaccines Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
